Back to AVLN

Catalio Capital Management, LP → AVLN

Catalio Capital Management, LP AVLN Position History

Avalyn Pharma Inc. • Healthcare

Quarters held
1
Latest value
$55.2M
Q2 2026
Peak value
$55.2M
First seen
Q2 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$55.2M1.68M——

Other funds holding AVLN

Other Catalio Capital Management, LP positions

DNTH

DIANTHUS THERAPEUTICS INC

$47M
LLY

ELI LILLY & CO

$43.8M
ABBV

ABBVIE INC

$35.9M
GILD

GILEAD SCIENCES INC

$35.5M
GILD

GILEAD SCIENCES INC

$35.5M
JNJ

JOHNSON & JOHNSON

$35.3M
CELG-RI

BRISTOL-MYERS SQUIBB CO

$34.9M
CELG-RI

BRISTOL-MYERS SQUIBB CO

$34.9M